Page 1385 - Problem-Based Feline Medicine
P. 1385
20 – THE CAT WITH ENLARGED LYMPH NODES 13771377
DRUG INDEX
24 on alternate weeks 24 24 24 on alternate weeks 24 24 if 48; reduce to 1/wk response 7 D 24 × 24 12–24 12 18 days of age at 12 12 24 8–12 12 12 Continued
IM, SC,PO PO PO PO IM PO SC PO, SC, IM PO PO PO PO IM IM PO PO PO PO IM, SC
15–30 U/cat 0.5–5.0 U/kg 1 U/cat 30 U/cat 20000 U/cat 10 U/cat 1 million U/kg 15–30 units/cat 50–100 mg/cat 20 mg/kg 0.25 ml/kg 2–6 ml/cat 15 mg/kg term) 50 mg/cat Induction: 5% Maintenance: 1.5–2.5% 0.25–0.50 ml/cat 0.5 tablet/cat 10–20 mg/kg 0.2–0.4 mg/kg block 0.2–1.0 mg/kg 0.5–0.8 mg/kg
Non-neoplastic FeLV- associated disease appetite stimulation FeLV FIP (nonexudative) FIP (exudative) herpes Ocular omega Immunostimulation (FIP) Immunostimulation Hyperthyroidism Hyperthroidism, Sporotrichosis Myelography Emetic Hyperthyroidism (short Anemia Anesthesia Urethical antispasmodic Tuberculosis Sinus bradycardia, SA or AV Antidiarrheal
(human 2b α Iodide sodium, potassium
Interferon-α 2 recombinant) Interferon, feline recombinant Interferon, human recombinant Iodine 20% solution Iopamidol Ipecac syrup Ipodate Iron dextran Isoflurane Isometheptene Isoniazid Isopropamide iodide Isopropamide/prochlor perazine